definiens: means, individually and collectively, any product for which the Partiesestablish and sign a Development Plan pursuant to Section 3.1 for development hereunder, which may include but notlimited to:(a ) Interferon beta-1b as a biosimilar product to the innovator product Betaseron ® /Betaferon ® from Bayer HealthCare Pharmaceuticals;(b ) PEGylated Interferon beta-1b;(c ) PEGylated Granulocyte Colony - Stimulating Factor ( PEG - GCSF ) as a biosimilar product to theinnovator product Neulasta ® from Amgen Inc.;(d ) PEGylated L - Asparaginase as a biosimilar product to Oncaspar ® from Sigma - TauPharmaceuticals Inc. ; and(e ) Human Growth Hormone ( HGH ) as a biosimilar product to Genotropin ® from Pfizer Inc